Company
Headquarters: Yangzhou, China
CN¥3.11 Billion
CNY as of Jan. 1, 2025
US$426.0 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells chemical raw materials, preparations, and organic intermediates in China. The company offers cardiovascular, anti-allergic, urinary, anti-infective, and immunomodulatory products. The company was founded in 2000 and is headquartered in Yangzhou, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Jiangsu Lianhuan Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600513 wb_incandescent